Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria
Top Cited Papers
Open Access
- 26 November 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 5, 643
- https://doi.org/10.3389/fmicb.2014.00643
Abstract
Polymyxins are polycationic antimicrobial peptides that are currently the last-resort antibiotics for the treatment of multidrug-resistant, Gram-negative bacterial infections. The reintroduction of polymyxins for antimicrobial therapy has been followed by an increase in reports of resistance among Gram-negative bacteria. Some bacteria, such as Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii, develop resistance to polymyxins in a process referred to as acquired resistance, whereas other bacteria, such as Proteus spp., Serratia spp. and Burkholderia spp., are naturally resistant to these drugs. Reports of polymyxin resistance in clinical isolates have recently increased, including acquired and intrinsically resistant pathogens. This increase is considered a serious issue, prompting concern due to the low number of currently available effective antibiotics. This review summarizes current knowledge concerning the different strategies bacteria employ to resist the activities of polymyxins. Gram-negative bacteria employ several strategies to protect themselves from polymyxin antibiotics (polymyxin B and colistin), including a variety of lipopolysaccharide (LPS) modifications, such as modifications of lipid A with phosphoethanolamine and 4-amino-4-deoxy-L-arabinose, in addition to the use of efflux pumps, the formation of capsules and overexpression of the outer membrane protein OprH, which are all effectively regulated at the molecular level. The increased understanding of these mechanisms is extremely vital and timely to facilitate studies of antimicrobial peptides and find new potential drugs targeting clinically relevant Gram-negative bacteria.Keywords
This publication has 138 references indexed in Scilit:
- Reciprocal Control between a Bacterium's Regulatory System and the Modification Status of Its LipopolysaccharideMolecular Cell, 2012
- Colistin Resistance inEscherichia coliandSalmonella entericaStrains Isolated from Swine in BrazilThe Scientific World Journal, 2012
- Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumanniiThe Journal of Infectious Diseases, 2011
- MicA sRNA links the PhoP regulon to cell envelope stressMolecular Microbiology, 2010
- A PhoQ/P‐regulated small RNA regulates sensitivity of Escherichia coli to antimicrobial peptidesMolecular Microbiology, 2009
- Colistin in the 21st centuryCurrent Opinion in Infectious Diseases, 2009
- Determination of pyrophosphorylated forms of lipid A in Gram-negative bacteria using a multivaried mass spectrometric approachProceedings of the National Academy of Sciences of the United States of America, 2008
- Periplasmic phosphorylation of lipid A is linked to the synthesis of undecaprenyl phosphateMolecular Microbiology, 2007
- An Undecaprenyl Phosphate-Aminoarabinose Flippase Required for Polymyxin Resistance in Escherichia coliJournal of Biological Chemistry, 2007
- An Outer Membrane Enzyme Encoded by Salmonella typhimurium lpxR That Removes the 3′-Acyloxyacyl Moiety of Lipid AOnline Journal of Public Health Informatics, 2006